Free Trial

Cardinal Health, Inc. $CAH Shares Sold by Swedbank AB

Cardinal Health logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Swedbank AB trimmed its stake in Cardinal Health by 3.0%, selling 12,765 shares and leaving 415,715 shares (0.17% ownership) valued at $85.43M, while institutional investors now hold 87.17% of CAH.
  • Analysts show a consensus rating of “Moderate Buy” with an average price target of $241.80 after several firms raised ratings and targets (e.g., Mizuho to $235 outperform, Argus to $248 buy, Wall Street Zen to strong‑buy).
  • Cardinal reported an EPS beat (Q EPS $3.17 vs. $2.79 est.) but missed revenue ($60.94B vs. $62.10B), set FY2026 guidance of $10.70–10.80 EPS, and increased its quarterly dividend to $0.5158 ($2.06 annual, ~1.1% yield).
  • MarketBeat previews the top five stocks to own by June 1st.

Swedbank AB decreased its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 415,715 shares of the company's stock after selling 12,765 shares during the quarter. Swedbank AB owned 0.17% of Cardinal Health worth $85,429,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of CAH. Redhawk Wealth Advisors Inc. boosted its holdings in shares of Cardinal Health by 0.5% in the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company's stock worth $1,902,000 after buying an additional 48 shares during the period. HF Advisory Group LLC raised its holdings in shares of Cardinal Health by 0.9% during the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company's stock valued at $1,074,000 after acquiring an additional 49 shares during the period. Latitude Advisors LLC raised its holdings in shares of Cardinal Health by 2.1% during the third quarter. Latitude Advisors LLC now owns 2,598 shares of the company's stock valued at $408,000 after acquiring an additional 53 shares during the period. Barnes Dennig Private Wealth Management LLC lifted its position in shares of Cardinal Health by 38.7% in the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company's stock valued at $39,000 after acquiring an additional 53 shares in the last quarter. Finally, MFA Wealth Services boosted its stake in Cardinal Health by 2.3% in the 3rd quarter. MFA Wealth Services now owns 2,491 shares of the company's stock worth $391,000 after purchasing an additional 55 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. Mizuho lifted their price objective on shares of Cardinal Health from $222.00 to $235.00 and gave the stock an "outperform" rating in a research report on Friday, February 6th. Wall Street Zen raised Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, May 2nd. Citigroup lowered their price target on Cardinal Health from $249.00 to $245.00 and set a "buy" rating on the stock in a report on Friday, May 1st. Zacks Research raised Cardinal Health from a "hold" rating to a "strong-buy" rating in a research report on Thursday, February 12th. Finally, Argus increased their price objective on Cardinal Health from $232.00 to $248.00 and gave the stock a "buy" rating in a research note on Wednesday, February 11th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $241.80.

Read Our Latest Stock Report on Cardinal Health

Cardinal Health Stock Down 2.8%

NYSE CAH opened at $191.41 on Thursday. The stock has a market capitalization of $44.83 billion, a PE ratio of 29.27, a price-to-earnings-growth ratio of 1.17 and a beta of 0.53. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60. The company has a 50 day moving average price of $212.52 and a two-hundred day moving average price of $206.74.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health's quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 1.1%. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health's dividend payout ratio is 31.19%.

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Read More

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines